Shanghai Medicilon Inc
SSE:688202
Shanghai Medicilon Inc
Operating Income
Shanghai Medicilon Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Medicilon Inc
SSE:688202
|
Operating Income
¥358.3m
|
CAGR 3-Years
72%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Operating Income
¥11.5B
|
CAGR 3-Years
52%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Operating Income
¥1.8B
|
CAGR 3-Years
18%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Operating Income
¥4.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Operating Income
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
34%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Operating Income
¥190.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Medicilon Inc's Operating Income?
Operating Income
358.3m
CNY
Based on the financial report for Dec 31, 2022, Shanghai Medicilon Inc's Operating Income amounts to 358.3m CNY.
What is Shanghai Medicilon Inc's Operating Income growth rate?
Operating Income CAGR 5Y
48%
Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for Shanghai Medicilon Inc have been 72% over the past three years , 48% over the past five years .